BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Docket Clock//docket-clock.pages.dev//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Considerations for the Use of the Plausible Mechanism Framew
X-PUBLISHED-TTL:PT12H
REFRESH-INTERVAL;VALUE=DURATION:PT12H
BEGIN:VEVENT
UID:2026-03713-close@docket-clock.pages.dev
DTSTAMP:20261017T145145Z
DTSTART;VALUE=DATE:20260427
DTEND;VALUE=DATE:20260428
SUMMARY:FDA comments close: Considerations for the Use of the Plausible Me
 chanism Framework To Develop Individualized Therapies That Target Specifi
 c Genetic Conditions With Known Biological Cause\; Draft Guidance for Ind
 ustry\; Availability
DESCRIPTION:Notice. Federal Register 2026-03713. Docket FDA-2026-D-1256. D
 etails: https://docket-clock.pages.dev/doc/2026-03713/ Official: https://
 www.federalregister.gov/documents/2026/02/25/2026-03713/considerations-fo
 r-the-use-of-the-plausible-mechanism-framework-to-develop-individualized-
 therapies
URL:https://www.federalregister.gov/documents/2026/02/25/2026-03713/consid
 erations-for-the-use-of-the-plausible-mechanism-framework-to-develop-indi
 vidualized-therapies
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR